← Thursday 29 Octobernote 6 of 11
Health researchThu 29 Oct 2026 · 6 of 11

New HS Management Guidelines Issue 37 Recommendations

Unsupported claims · 4/5 supported1 cited · 1 min read

Medical Xpress reports that evidence‑based recommendations for the management of hidradenitis suppurativa were issued by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation and published online on Oct. 20 in the Journal of the American Academy of Dermatology . Medical Xpress reports that Haley B. Naik, M.D., and colleagues from the University of California, San Francisco conducted a systematic review that produced 37 evidence‑based recommendations . Medical Xpress reports that the strongly recommended treatments include adalimumab, bimekizumab, infliximab, secukinumab, and routine pain assessment . Medical Xpress reports that conditional recommendations cover topical therapies such as clindamycin, resorcinol and ruxolitinib, systemic antibiotics including oral doxycycline, tetracycline, clindamycin with rifampin and intravenous ertapenem, as well as hormone therapy with spironolactone, short‑term systemic corticosteroids and upadacitinib, plus procedural interventions and tobacco cessation .

Why it matters. Medical Xpress reports that clinicians can apply the 37 recommendations to guide treatment decisions for patients with hidradenitis suppurativa .

Earlier on Health research

Wed 28 Oct 2026Cochrane review finds workplace ergonomics offer little benefit for CANSMedical Xpress reports that an updated Cochrane review found ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work‑related arm, neck or shoulder complaints (CANS) compared with no treatment. Medical Xpress reports that the review analyzed 20 trials involving 2,478 people with work‑related CANS, of which 16 examined nonspecific CANS and included many computer‑using workers. Medical Xpress reports that workplaces invest heavily in ergonomic measures such as office furniture changes and biomechanical or ergonomic education to help office workers with CANS. Medical Xpress reports that CANS disorders develop from repetitive movements, awkward postures or external forces and significantly affect working populations worldwide.Tue 27 Oct 2026Heme shown to inhibit clot‑dissolving enzyme, study findsMedical Xpress reports that heme, a component of hemoglobin, can inhibit the enzyme plasmin that helps dissolve blood clots. Medical Xpress reports that the research was conducted by a team at the University of Koblenz led by Prof. Dr. Marie‑T. Hopp. Medical Xpress reports that the findings were published in the International Journal of Biological Macromolecules. Medical Xpress reports that the study provides a new molecular approach to understand the link between hemolysis and an increased risk of thrombosis.Mon 26 Oct 2026Bispecific ADC doubles PFS in HR+/HER2‑ breast cancerClinical Trials Arena reports that an $8.4bn bispecific ADC doubles progression‑free survival in HR+/HER2‑ breast cancer. Clinical Trials Arena reports that bispecific ADCs are viewed as the next generation of ADC development. Clinical Trials Arena reports that they continue to be the focus of high‑value dealmaking.
Next · Formula 12026 F1 driver contracts: key expiry dates and upcoming uncertainties →